GlassScriptPhysician profile
Shruti U Mankad
NPI 1447379714
$853.44
in general payments reported to CMS, 2019-2025
9 companies · $226 in 2025
The $226 reported for 2025 was more than what 78% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $152 · 2022: $111 · 2023: $184 · 2024: $16.80 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306 · Education: $110 · Gift: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $306.39 |
| Education | $110.00 |
| Gift | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $222.54 | 2022-2023 | |
| Align Technology, INC. | $176.78 | 2023-2025 | Invisalign, Invisalign First - Comprehensive |
| A-Dec, INC. | $130.00 | 2020 | |
| Dentsply Sirona INC | $104.64 | 2019-2025 | Mis |
| Zimmer Biomet Holdings, INC. | $101.60 | 2019 | |
| Purelife, LLC | $50.00 | 2019-2025 | |
| Hu-Friedy Mfg. Co., LLC | $40.00 | 2025 | |
| Voco America INC. | $16.80 | 2024 | Futurabond U, Voco Profluorid Varnish, Admira Fusion |
| Dexcel Pharma Technologies LTD. | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shruti Mankad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.